| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 25.863 | 100.901 | 173.170 | 235.684 | 355.215 | 396.977 |
| Total Income - EUR | - | - | - | - | 27.837 | 104.461 | 177.292 | 253.288 | 359.292 | 400.887 |
| Total Expenses - EUR | - | - | - | - | 26.043 | 71.470 | 139.495 | 217.186 | 250.375 | 283.025 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.795 | 32.991 | 37.797 | 36.102 | 108.916 | 117.862 |
| Net Profit/Loss - EUR | - | - | - | - | 1.588 | 32.209 | 36.845 | 34.326 | 106.180 | 107.728 |
| Employees | - | - | - | - | 1 | 2 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Derma Napocensis S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 33.747 | 29.700 | 293.442 | 381.101 | 513.418 | 639.349 |
| Current Assets | - | - | - | - | 11.478 | 29.345 | 32.355 | 34.432 | 58.144 | 10.420 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 517 |
| Receivables | - | - | - | - | 7.765 | 260 | 2.721 | 4.595 | 8.117 | 1.987 |
| Cash | - | - | - | - | 3.713 | 29.085 | 29.634 | 29.837 | 50.027 | 7.915 |
| Shareholders Funds | - | - | - | - | 1.630 | 32.259 | 68.389 | 117.913 | 223.736 | 312.723 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 112 | 111 | 111 |
| Debts | - | - | - | - | 14.905 | 1.995 | 236.576 | 280.209 | 333.944 | 326.712 |
| Income in Advance | - | - | - | - | 28.961 | 24.858 | 20.832 | 17.411 | 13.883 | 10.350 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Derma Napocensis S.r.l.